Growing community of inventors

Dusseldorf, Germany

Matthieu Philippe Victor Willot

Average Co-Inventor Count = 7.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 9

Matthieu Philippe Victor WillotLieven Meerpoel (3 patents)Matthieu Philippe Victor WillotOlivier Alexis Georges Querolle (3 patents)Matthieu Philippe Victor WillotChristophe Meyer (3 patents)Matthieu Philippe Victor WillotDidier Jean-Claude Berthelot (3 patents)Matthieu Philippe Victor WillotPatrick Rene Angibaud (2 patents)Matthieu Philippe Victor WillotThierry Francois Alain Jean Jousseaume (2 patents)Matthieu Philippe Victor WillotPatrick René Angibaud (1 patent)Matthieu Philippe Victor WillotThierry François Alain Jean Jousseaume (1 patent)Matthieu Philippe Victor WillotChristophe Meyer (1 patent)Matthieu Philippe Victor WillotMatthieu Philippe Victor Willot (3 patents)Lieven MeerpoelLieven Meerpoel (97 patents)Olivier Alexis Georges QuerolleOlivier Alexis Georges Querolle (32 patents)Christophe MeyerChristophe Meyer (25 patents)Didier Jean-Claude BerthelotDidier Jean-Claude Berthelot (23 patents)Patrick Rene AngibaudPatrick Rene Angibaud (30 patents)Thierry Francois Alain Jean JousseaumeThierry Francois Alain Jean Jousseaume (4 patents)Patrick René AngibaudPatrick René Angibaud (65 patents)Thierry François Alain Jean JousseaumeThierry François Alain Jean Jousseaume (1 patent)Christophe MeyerChristophe Meyer (12 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Janssen Pharmaceutica Nv (3 from 2,078 patents)


3 patents:

1. 11267804 - (R)-8-(1-((3-fluorophenyl)amino)ethyl)-N-(2-hydroxyethyl)-2-morpholinoquinoxaline-6-carboxamide for inhibiting phosphoinositide-3-kinase activity

2. 11130751 - Quinoxaline and pyridopyrazine derivatives as PI3K-beta inhibitors

3. 10526316 - Quinoxaline and pyridopyrazine derivatives as PI3Kβ inhibitors

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/4/2026
Loading…